Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency
Jin‐Ho Choi(CHA University), Han‐Wook Yoo(Ulsan College), Jahyang Cho(Ulsan College), Yoo‐Mi Kim(Ulsan College), Chong Kun Cheon(Pusan National University Yangsan Hospital), Jung Min Ko(Ulsan College), Ja Hye Kim(Hanyang University Guri Hospital), Jung Hyun Lee(University of Washington), Beom Hee Lee(Ulsan College), Gu-Hwan Kim(Asan Medical Center)
Cited by 49
Related Papers
miR-29 miRNAs activate p53 by targeting p85α and CDC42
|Nature Structural & Molecular Biology|2008|606
Microbial Symbiosis in Marine Sponges
|The Journal of Microbiology|2001|223
PKR is activated by cellular dsRNAs during mitosis and acts as a mitotic regulator
|Genes & Development|2014|143
Deletion of Human tarbp2 Reveals Cellular MicroRNA Targets and Cell-Cycle Function of TRBP
|Cell Reports|2014|123
Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease
|Journal of neurosurgery|2015|116